1

Identity

Merck Sharp & Dohme de España, S.A.

A28211092

€750M

Amount awarded, solo awards 2016–2026

Amount awarded by year
YearAmountDistribution
2026*€152.4M
2025€235.1M
2024€79.7M
+ regional platforms
2023€100.9M
2022€78.2M
2021€48.5M
2020€15.0M
2019€26.1M
2018€8.0M
2017€5.1M
2016€1.1M
*2026: data to 31 October · 108 contracts in 2026 · Since 2024 this also includes data from regional platforms. · Solo awards, excluding JVs · Framework agreements at €0 · €M
1,033
Contracts (lots)
across 760 tenders
58
Buyers
81%
Single bidder
7
Awards in UTEs
not in the total

In figures

Volume

Between 2016 and 2026 it won 1,033 contracts worth €750M on its own, with 58 buyers. Its 7 joint-venture (UTE) contracts are shown separately.

Price

In 2024–2026 its median discount was 13.1%; the middle half of its discounts between 5.7% and 25.2% (12 comparable awards).

Competition

Since 2024, 50% of its comparable value was won with a discount and against other bidders. It was the only bidder in 81% of its contracts (2016–2026).

Renewals

43 contracts (€69.4M) come up for tender again in the next 24 months.

A UTE is a temporary joint venture: the contract is awarded to the UTE and each partner's share is not published. That is why these contracts are not added to Merck Sharp & Dohme de España, S.A.'s total, and under «Show UTEs» the amounts are the full value of each contract (100%), not Merck Sharp & Dohme de España, S.A.'s share.

Data up to 31 October 2026 · updated on 12 November 2026 · Source: official data, national and regional coverage

2

Its discounts

The discount at which it wins contested contracts, year by year.

2024–2026: median 13.1% · middle half between 5.7% and 25.2% · 12 awards

2019–2023: median 25.3% (9 awards) · 2024–2026: median 13.1% (12 awards).

2019–2026: median 15.2% · middle half between 4.3% and 28.9% · 21 awards

Discount on the tender budget, excluding VAT, on awards above the minor-contract threshold · Source: official data, national and regional coverage. Methodology →

Where it wins, and at what discount

In the report · these discounts, one by one

Each dot on the chart is an award. The report lists them all and groups them by buyer and by sector, next to the discounts of other companies with the same buyers.

By sector

Productos farmacéuticos

CPV 336

448 contracts · €465M

By buyer · 2024–2026

Servicio Murciano de Salud - Junta de Compras

Productos farmacéuticos

4 contracts · €3.93M

Request the report →

Full list: date, buyer, amount, budget, discount, bidders and a link to the official publication.

Distribution of its discounts
How far winning bids are below the published contract value — its contested awards, the same ones the chart shows.
Median discount: 13.1% below the published contract value · 12 awards (2024–2026).
Discount
Awards
0–5 %
3
5–15 %
3
15–30 %
4
30 %+
2

4 awards at the tender price, left out of the discounts.

3

How it wins

Whether it wins with or without competition.

Competition and pricing

50% of the comparable value since 2024 (€13.0M of €26.0M) was won with a discount and against other bidders. €10.0M (39%) was awarded with a discount and without other bidders.

With a discount
39%
single bidder · 8 · €10.0M
50%
multiple bidders · 12 · €13.0M
At the tender price
12%
single bidder · 11 · €3.03M
0%
multiple bidders · 0

Comparable: 31 awards with a published budget and bidder count (€26.0M of €467M awarded since 2024). Percentages of value; the figure next to «bidders» is the number of awards. Source: official data, national and regional coverage.

Award procedure

Between 2016 and 2026, 68.0% of the value was awarded through negotiated without publicity procedure (38.2% of contracts); followed by Open (13.4%) and Based on a framework agreement (12.0%).

Open · 13.4%
Based on a framework agreement · 12.0%
Negotiated without publicity · 68.0%
Open
Simplified open
Based on a framework agreement
Negotiated without publicity
Other
4

Upcoming tenders and main buyers

When its contracts come back and who it sells to.

When its contracts come back

In the next 24 months 43 of its contracts come up for tender again, worth €69.4M.

Expected endBuyerValue
2026Gerencia de Servicio Sanitarios de Fuerteventura€492k
2026Gerencia de Servicio Sanitarios de Fuerteventura€38.0k
2026Gerencia de Servicio Sanitarios de Fuerteventura€8.70k
2026Gerencia de Servicio Sanitarios de Fuerteventura€5.73k
2026Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad—

and 38 more in the next 24 months · the report includes them all

Expected end year from the published duration (no extensions). The report includes the month and the discount it won each one at.

Who they sell to
BuyerContractsValue, €Period
Departament de Salut35112 M2020–2026
OSAKIDETZA - Servicio Vasco de Salud -Director General1281 M2024–2026
Gerencia de Servicio Sanitarios de Fuerteventura29379 M2018–2026
Dirección General de Planificación Económica4265 M2018–2026
Consejería de Sanidad (Comunidad de Madrid)949 M2024–2026

and 53 more buyers

Sector activity
Top CPV codes — the EU classification system that identifies the type of works, services or supplies covered by each contract.

Between 2016 and 2026, 100.0% of the value it won on its own is in Medical & pharmaceuticals (CPV 33, 1,005 contracts).

Medical & pharmaceuticals
100.0%1005 contracts
Furniture & cleaning supplies
<0.1%2 contracts
5

Recent awards

The evidence behind every insight in the report.

Latest 5 completed contracts (of 377)
Contracts whose expected completion date has passed.
DateContractBuyerBiddersValue
17/06/20262º cbam con merck sharp & dohme de españa, s.a. expte. 88/2025. am suministro de vacunas frente al …Servicio Andaluz de Salud2€237k
30/04/2026LOTE 18 Vacuna frente a rotavirusConsejería de Sanidad del Gobierno de Canarias2€644k
01/04/2026Suministro de medicamento raltegravir para hospitales Asepeyo Sant Cugat y CosladaSubdirección General Sanitaria de ASEPEYO. Mutua Colaboradora con la Seguridad Social. num. 1511€20.7k
11/03/2026cordoba 5ª prorroga 7º cbam merck sharp & dohme de españa, s.a. para suministro de tracto sucesivo …Servicio Andaluz de Salud1€52.2k
02/03/20263º Contrato derivado de Acuerdo Marco, Suministro de ISENTRESS 400 MG® para los Centros Penitenciar…Subdirección General de Planificación y Gestión Económica1€10.5k
Full report on Merck Sharp & Dohme de España, S.A.
Includes: its discount by buyer and sector · winning discounts by buyer and year · how it wins with each buyer · contract renewal calendar. The complete register of its awards in the last three full calendar years and the current year to date, in Excel.
€50 + VAT · VAT is calculated at payment according to your country. You will receive it in PDF and Excel by email within one working day. Every report is reviewed by a person before it is sent to you.
Order the report